Evidence map›Paper›PMID 32301585›Full record

ReviewCancer communications (London, England)2020

Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy.

Wei Chang Colin Tan, Sanjna Nilesh Nerurkar, Hai Yun Cai, Harry Ho Man Ng, Duoduo Wu, Yu Ting Felicia Wee, Jeffrey Chun Tatt Lim, Joe Yeong, Tony Kiat Hon Lim

Abstract readReview
In one paragraph

Review in Cancer communications (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 361 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
361citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

361 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Spatial Transcriptomics Analysis of Ewing Sarcoma.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  5. Immunophenotyping by Spatial Biology.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  6. Article
  7. Article
  8. Review
  9. Emerging technologies in the spatial proteomics landscape.Analytical and bioanalytical chemistry · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

301 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei Chang Colin TanYong Loo Lin School of Medicine, National University of Singapore, Singapore, 169856, Singapore.
Sanjna Nilesh NerurkarYong Loo Lin School of Medicine, National University of Singapore, Singapore, 169856, Singapore.
Hai Yun CaiYong Loo Lin School of Medicine, National University of Singapore, Singapore, 169856, Singapore.
Harry Ho Man NgDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, 169856, Singapore.
Duoduo WuYong Loo Lin School of Medicine, National University of Singapore, Singapore, 169856, Singapore.
Yu Ting Felicia WeeDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, 169856, Singapore.
Jeffrey Chun Tatt LimInstitute of Molecular Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, 169856, Singapore.
Joe YeongDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, 169856, Singapore.
Tony Kiat Hon LimDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, 169856, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional immunohistochemistry (IHC) is a widely used diagnostic technique in tissue pathology. However, this technique is associated with a number of limitations, including high inter-observer variability and the capacity to label only one marker per tissue section. This review details various highly multiplexed techniques that have emerged to circumvent these constraints, allowing simultaneous detection of multiple markers on a single tissue section and the comprehensive study of cell composition, cellular functional and cell-cell interactions. Among these techniques, multiplex Immunohistochemistry/Immunofluorescence (mIHC/IF) has emerged to be particularly promising. mIHC/IF provides high-throughput multiplex staining and standardized quantitative analysis for highly reproducible, efficient and cost-effective tissue studies. This technique has immediate potential for translational research and clinical practice, particularly in the era of cancer immunotherapy.

Indexed as

Fluorescent Antibody TechniqueHumansImmunohistochemistryImmunotherapyNeoplasmsimmunofluorescenceimmunohistochemistryimmunotherapymultiplexoverview

Identifiers

PMID32301585
PMCPMC7170662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.